REQUEST A DEMO
Total
USD $0.00
Search more companies

Genexone S.R.O. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Genexone S.R.O. Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Genexone S.R.O. is a company in Czech Republic, with a head office in Olomouc. The company operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on June 02, 2008. The total number of employees is currently 6 - 9 (2025). From the latest financial highlights, Genexone S.R.O. reported a net sales revenue increase of 4.17% in 2024. Its’ total assets recorded a negative growth of 20.16%. Genexone S.R.O.’s net profit margin increased by 19.36% in 2024.

Headquarters
Legionarska 1319/10
Olomouc; Olomoucky; Postal Code: 77900

Contact Details: Purchase the Genexone S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Genexone S.R.O. report to view the information.
Registered Capital:
Purchase the Genexone S.R.O. report to view the information.
Financial Auditors:
Purchase the Genexone S.R.O. report to view the information.
Incorporation Date:
June 02, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Genexone S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
4.17%
Total operating revenue
4.39%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
97.5%
Total assets
-20.16%
Total equity
-4.79%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
19.36%
Return on Equity (ROE)
178.73%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?